11/19/2014 – Salix Pharmaceuticals Ltd.
Issued: 11/16/2014
Salix pharmaceuticals, SLXP:
1. Salix pharmaceuticals is now in a ‘Buy‘ position based upon Friday’s strong close (Friday’s close $102.32).
2. A test/attempt at $106/$07 is expected into early next week (week of Nov. 17).
3. Partial long position profits should be taken at/near $104.00, a further portion exited at/near $106.00, and the remainder held for a trend following exit to be messaged in a subsequent update.
4. Once long, a protective sell stop should be placed at $98.60. This stop will be moved higher as the market continues to confirm. Will update.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. We remain long Salix pharmaceuticals based upon Friday’s strong close (Friday’s close/long entry at $102.32).
2. Partial long position profits should be taken at/near $104.00, a further portion exited at/near $106.00, and the remainder held for a trend following exit to be messaged in a subsequent update.
3. Salix remains firm but may not be acting as well as it could.
4. Our protective stop has been raised and $99.80. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. Exit an initial portion of your long position in Salix pharmaceuticals at current prices (current price $103.07).
2. Our protective sell stop is been raised to $100.50. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. Today (Tuesday, Nov. 18) Salix pharmaceuticals completed the forecast advance from $102.32 (directed long entry) to our final long position profit target at $106/$07, expected to complete early during this week (week of Nov. 17). Today’s session high, was $106.10.
2. It is assumed that the majority of long positions from $102.30 were exited at/near $106.00. Any remaining long positions can be held for the possibility of higher prices. Will update.
3. Our protective stop has been raised $102.48. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/19/2014
Salix pharmaceuticals, SLXP:
1. Those holding any remaining long positions in Salix should raise their protective sell stop now to $103.40. This stop will continue to be moved higher as the market continues to confirm.
2. Final long position exit should be taken at/near $107.00 as noted in the original forecast.
David Williams
Issued: 11/19/2014
Salix pharmaceuticals, SLXP:
1. Today (Wed., Nov. 19) Salix pharmaceuticals completed the forecast $107.00 final upside target noted in previous updates (today’s session high $106.95).
2. Traders holding any remaining long positions exited at/near $107.00, completing the trade. Will message any further entry or indication in Salix pharmaceutical.
David Williams
CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.